Boundless Bio Inc. (BOLD) Price to Earnings Multiple

Corporate emblem and logo of Boundless Bio, Inc (BOLD)

The daily price chart for Boundless Bio, Inc. (BOLD), which develops DNA-based medical products, demonstrates the -0.90 indicator. Business protection is ensured by exclusive oncology patents and influence within government agencies under strict FDA supervision. High automation via sequencing robots eliminates manual labor during data analysis. Boundless Bio, Inc. (BOLD) currently relies on venture capital investments, as commercial sales are absent and no cash flow is being generated.

boundlessbio.com - BOLD Price to Earnings Ratio (period 08/14/2024 - 11/10/2026)

Analytical breakdowns for Boundless Bio, Inc.

- price and consensus price forecast:
Stock Price boundlessbio.com|BOLD - Price Target Chart
- market capitalization details:
Market Capitalization Boundless Bio, Inc.|BOLD - Enterprise Value
- issuer book value statistics:
Equity per Share Boundless Bio|BOLD - Company Book Value|Market Value to Book Value Ratio boundlessbio.com|BOLD - Company Total Assets
- debt and solvency information:
Debt to Capital Boundless Bio, Inc.|BOLD - Long-Term Debt to Equity|Short-Term Debt to Capital Coefficient Boundless Bio Inc|BOLD - Company Debts|Debts to Net Assets Boundless Bio, Inc.|BOLD - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings Boundless Bio|Quick Liquidity boundlessbio.com
- financial results and valuation multiples details:
BOLD - Net Profit|Company Profit Forecast Boundless Bio, Inc.|BOLD - Price to Earnings Ratio|Projected Price to Earnings Ratio Boundless Bio Inc.|BOLD - Price/Earnings to Growth Multiple|Business Value to Operating Income Before Depreciation Boundless Bio, Inc.|BOLD - Operating profit EBITDA|Net earnings per share for the last four quarters Boundless Bio|BOLD - Earnings per share for the last twelve months|Year-over-year earnings per share growth for the last 12 months boundlessbio.com|BOLD - Earnings growth in current year|Expected earnings per share growth for next year Boundless Bio, Inc.
Comprehensive company analysis:Boundless Bio, Inc.
Original product of Boundless Bio, Inc.

For Boundless Bio, Inc., which invests in innovative oncology treatments, the P/E ratio serves as an indicator of how effectively scientific developments are capitalized relative to current earnings. By analyzing the issuer's P/E history, an investor evaluates the ratio of the stock's market value to net income per share, which helps determine the extent of the premium paid for the company's future technological successes amid inflationary pressures.

Competing companies

P/E Multiple Tempus AI Inc|Price to Earnings Ratio Qiagen (QGEN)|Ionis Pharmaceuticals, Inc. - Price to Earnings Multiple|P/E Multiple RGEN (Repligen Corp.)|RNA: Price to Earnings Multiple|CRSP - Price to Earnings Ratio|WGS: Price to Earnings Ratio|RARE: P/E Multiple|Market Cap to Earnings Beam Therapeutics Inc (BEAM)|Price to Earnings Ratio Sarepta Therapeutics Inc|Twist Bioscience Corp (TWST) - Business Payback Period|Price to Earnings Ratio 10x Genomics, Inc. (TXG)|Business Payback Period intelliatx.com|Stoke Therapeutics, Inc. - Price to Earnings Ratio|Company Value to Net Income BLFS|Wave Life Sciences Corp - P/E Multiple|MAZE: Price to Earnings Ratio|SION: P/E Multiple|PRME - Business Payback Period|Price to Earnings Ratio Taysha Gene Therapies, Inc.|Market Cap to Earnings uniQure NV QURE|Price to Earnings Ratio MGTX (MeiraGTx PLC)|RGNX (REGENXBIO Corp) - Company Value to Net Income|P/E Multiple SLDB (Solid Biosciences Inc.)|Business Payback Period ocugen.com (OCGN)|PACB - Price to Earnings Ratio|BNTC (Benitec Biopharma Inc) - Price to Earnings Multiple|DSGN: P/E Multiple|Price to Earnings Ratio Rocket Corp|Price to Earnings Ratio FDMT|Lexeo (LXEO) - Business Payback Period|P/E Multiple KRRO|Price to Earnings Ratio EDIT (Editas Medicine Inc)|Price to Earnings Ratio Silence Therapeutics Inc. SLN|ProQR (PRQR) - Market Cap to Earnings|CDXS - Price to Earnings Ratio|SGMO: Price to Earnings Ratio|NAUT: P/E Multiple|Price to Earnings Multiple MGX|DTIL (Precision BioSciences, Inc.) - P/E Multiple|Price to Earnings Multiple GBIO (Generation Bio Corp)|Price to Earnings Ratio Exicure, Inc. (XCUR)|imunon.com - Price to Earnings Multiple|P/E Multiple PHIO (Phio Pharmaceuticals Corp.)|P/E Multiple Mustang Bio Inc MBIO|TransCode - P/E Multiple|BNGO: Price to Earnings Ratio|Applied DNA Sciences (APDN) - Price to Earnings Ratio|Market Cap to Earnings bluebirdbio.com (BLUE)|Price to Earnings Ratio IPA|P/E Multiple Omega Therapeutics Inc|Price to Earnings Ratio Singular Genomics Systems Inc (OMIC)|Regulus - Price to Earnings Multiple|P/E Multiple SYRS (Syros Pharmaceuticals)|TBIO: Price to Earnings Multiple|TCON - Price to Earnings Ratio|UBX: Price to Earnings Ratio